Annual Revenue
$682.16M$301.54M-30.65%
Summary
- Current Value
- As of today, NVAX annual revenue is $682.16M, down -30.65% on
- Historical Performance
- NVAX annual revenue is down -40.49% over the past 3 years, and up +3555.35% over the past 5 years
- All-Time High Comparison
- NVAX annual revenue is currently -65.58% below its historical high of $1.98B set on
- 3-Year Low Comparison
- NVAX annual revenue is at its 3-year low
- Sector Comparison
- NVAX annual revenue is higher than 82.98% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate NVAX annual revenue at $1.06B, +55.78% higher than the current value
- Upcoming Earnings
- The next annual earnings release for NVAX is on
Revenue Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Revenue | $682.16M | -30.6% | -40.5% | +3555.3% | +10000.0% | |
| Quarterly Revenue | $70.45M | -16.6% | -90.4% | -55.1% | +10000.0% | |
| TTM Revenue | $1.06B | +20.3% | -42.4% | +420.0% | +10000.0% | |
| Price | $7.78 | -9.0% | -36.7% | -93.9% | -84.5% | |
| Annual EPS | -$1.23 | +77.2% | +94.7% | +77.6% | +86.3% | |
| PE Ratio | 4.40 | – | – | – | – | |
| Annual Gross Profit | $484.22M | -31.2% | -57.3% | +100.0% | +100.0% | |
| Annual Net Income | -$187.50M | +65.6% | +89.3% | -41.3% | -388.6% | |
| Annual EBITDA | -$183.47M | +50.9% | +89.0% | -48.2% | -407.0% | |
| Annual EBIT | -$231.97M | +44.1% | +86.3% | -79.0% | -520.5% |
Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.98B | N/A | -65.6% |
| 5Y | $1.98B | -65.6% | |
| All | $1.98B | -65.6% |
Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $682.16M | at low | |
| 5Y | $475.60M | N/A | +43.4% |
| All | $55.50K | >+9999.0% |
Revenue Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.01B | $983.71M | -3.03% | |
| $684.95M | $682.16M | -0.41% | |
| $1.06B | N/A | +55.78% | |
| $459.01M | N/A | -32.71% |
🔒 Log In To Unlock Full Data
Revenue History
FAQ
What is the current annual revenue of NVAX?
As of today, NVAX annual revenue is $682.16M
What is 1-year change in NVAX annual revenue?
NVAX annual revenue is down -30.65% year-over-year
What is 3-year change in NVAX annual revenue?
NVAX annual revenue is down -40.49% over the past 3 years
How far is NVAX annual revenue from its all-time high?
NVAX annual revenue is currently -65.58% below its historical high of $1.98B set on December 31, 2022
How does NVAX annual revenue rank versus sector peers?
NVAX annual revenue is higher than 82.98% of companies in Healthcare sector
How does the analyst estimate for NVAX annual revenue compare to its current value?
Analysts estimate NVAX annual revenue at $1.06B, +55.78% higher than the current value
When is NVAX next annual earnings release?
The next annual earnings release for NVAX is on
Quarterly Revenue
$70.45M$168.80M-70.55%
Summary
- Current Value
- As of today, NVAX quarterly revenue is $70.45M, down -70.55% on
- Historical Performance
- NVAX quarterly revenue is down -16.64% year-over-year, and down -90.41% over the past 3 years
- All-Time High Comparison
- NVAX quarterly revenue is currently -90.41% below its historical high of $734.58M set on
- 3-Year Low Comparison
- NVAX quarterly revenue is at its 3-year low
- Sector Comparison
- NVAX quarterly revenue is higher than 73.90% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate NVAX quarterly revenue at $90.26M, +28.13% higher than the current value
- Upcoming Earnings
- The next earnings release for NVAX is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Revenue | $70.45M | -70.5% | -16.6% | -90.4% | -55.1% | |
| Annual Revenue | $682.16M | – | -30.6% | -40.5% | +3555.3% | |
| TTM Revenue | $1.06B | -1.3% | +20.3% | -42.4% | +420.0% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| Quarterly EPS | -$1.25 | -307.4% | -64.5% | +42.1% | +61.1% | |
| PE Ratio | 4.40 | -12.7% | – | – | – | |
| Quarterly Gross Profit | $50.65M | -77.5% | +97.1% | -82.6% | +100.0% | |
| Quarterly Net Income | -$202.38M | -290.0% | -66.8% | -20.0% | -2.6% | |
| Quarterly EBIT | -$79.40M | -175.1% | +38.8% | +37.6% | +58.9% | |
| Quarterly EBITDA | -$72.82M | -164.3% | +37.8% | +38.7% | +62.1% |
Quarterly Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $666.66M | -89.4% | |
| 3Y | $666.66M | -89.4% | |
| 5Y | $734.58M | -90.4% | |
| All | $734.58M | -90.4% |
Quarterly Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $70.45M | at low | |
| 3Y | $70.45M | at low | |
| 5Y | $70.45M | at low | |
| All | $7,000.00 | >+9999.0% |
Quarterly Revenue Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $165.01M | $239.24M | +44.98% | |
| $44.87M | $70.45M | +56.99% | |
| $90.26M | N/A | +28.13% | |
| $114.53M | N/A | +62.58% |
🔒 Log In To Unlock Full Data
Quarterly Revenue History
FAQ
What is the current quarterly revenue of NVAX?
As of today, NVAX quarterly revenue is $70.45M
What is NVAX quarterly revenue most recent change?
NVAX quarterly revenue was down -70.55% on September 30, 2025
What is 1-year change in NVAX quarterly revenue?
NVAX quarterly revenue is down -16.64% year-over-year
How far is NVAX quarterly revenue from its all-time high?
NVAX quarterly revenue is currently -90.41% below its historical high of $734.58M set on September 30, 2022
How does NVAX quarterly revenue rank versus sector peers?
NVAX quarterly revenue is higher than 73.90% of companies in Healthcare sector
How does the analyst estimate for NVAX quarterly revenue compare to its current value?
Analysts estimate NVAX quarterly revenue at $90.26M, +28.13% higher than the current value
When is NVAX next earnings release?
The next earnings release for NVAX is on
TTM Revenue
$1.06B$14.07M-1.30%
Summary
- Current Value
- As of today, NVAX TTM revenue is $1.06B, down -1.30% on
- Historical Performance
- NVAX TTM revenue is up +20.27% year-over-year, and down -42.35% over the past 3 years
- All-Time High Comparison
- NVAX TTM revenue is currently -46.28% below its historical high of $1.98B set on
- 3-Year Low Comparison
- NVAX TTM revenue is +56.07% above its 3-year low of $682.16M reached on
- Sector Comparison
- NVAX TTM revenue is higher than 84.57% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate NVAX TTM revenue at $1.07B, +0.18% higher than the current value
- Upcoming Earnings
- The next earnings release for NVAX is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Revenue | $1.06B | -1.3% | +20.3% | -42.4% | +420.0% | |
| Annual Revenue | $682.16M | – | -30.6% | -40.5% | +3555.3% | |
| Quarterly Revenue | $70.45M | -70.5% | -16.6% | -90.4% | -55.1% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| TTM EPS | $1.77 | -21.6% | +178.3% | +110.2% | +133.9% | |
| PE Ratio | 4.40 | -12.7% | – | – | – | |
| TTM Gross Profit | $964.55M | +2.7% | +62.8% | -12.3% | +100.0% | |
| TTM Net Income | $341.75M | -19.2% | +220.0% | +125.8% | +225.4% | |
| TTM EBITDA | $451.74M | +10.9% | +285.8% | +137.6% | +276.5% | |
| TTM EBIT | $416.73M | +13.8% | +243.7% | +134.0% | +260.3% |
TTM Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.25B | -15.2% | |
| 3Y | $1.98B | N/A | -46.3% |
| 5Y | $1.98B | -46.3% | |
| All | $1.98B | -46.3% |
TTM Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $682.16M | N/A | +56.1% |
| 3Y | $682.16M | +56.1% | |
| 5Y | $475.60M | N/A | +123.9% |
| All | $100.00K | >+9999.0% |
TTM Revenue History
FAQ
What is the current TTM revenue of NVAX?
As of today, NVAX TTM revenue is $1.06B
What is NVAX TTM revenue most recent change?
NVAX TTM revenue was down -1.30% on September 30, 2025
What is 1-year change in NVAX TTM revenue?
NVAX TTM revenue is up +20.27% year-over-year
How far is NVAX TTM revenue from its all-time high?
NVAX TTM revenue is currently -46.28% below its historical high of $1.98B set on December 31, 2022
How does NVAX TTM revenue rank versus sector peers?
NVAX TTM revenue is higher than 84.57% of companies in Healthcare sector
How does the analyst estimate for NVAX TTM revenue compare to its current value?
Analysts estimate NVAX TTM revenue at $1.07B, +0.18% higher than the current value
When is NVAX next earnings release?
The next earnings release for NVAX is on
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax